Dysphagia in Parkinson's disease. Assessment by solid phase radionuclide scintigraphy

Area of Science:

• Gastroenterology
• Neurology
• Nuclear Medicine

Background:

• Parkinson's disease (PD) frequently causes dysphagia, impacting quality of life.
• Dysphagia in PD involves impaired esophageal motility.
• Radionuclide solid phase esophageal motility studies offer a quantitative method to assess esophageal function.

Purpose of the Study:

• To evaluate esophageal motility in Parkinson's disease patients using a radionuclide solid phase study.
• To compare esophageal transit parameters between PD patients and healthy controls.
• To explore the potential of this study as a monitoring tool for dysphagia in PD.

Main Methods:

• A radionuclide solid phase esophageal motility study was performed on 27 PD patients and 27 age-matched controls.
• Subjects ingested a gelatin bolus labeled with Technetium-99m pertechnetate.
• Esophageal transit time, residual fraction, and retrograde index were calculated using gamma camera imaging and computer analysis.

Main Results:

• Parkinson's disease patients exhibited significantly prolonged mean transit times compared to controls.
• Preliminary findings suggest that dysphagia associated with Parkinson's disease may be responsive to medication.
• The study identified potential differences in esophageal motility parameters between PD patients and controls.

Conclusions:

• Radionuclide solid phase esophageal motility studies can detect significant esophageal transit abnormalities in Parkinson's disease.
• These findings support the use of this technique for monitoring dysphagia in PD.
• Further research may confirm the efficacy of medication in improving esophageal motility in PD patients.